{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:24:39Z","timestamp":1786994679469,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2019016"],"award-info":[{"award-number":["2019016"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2016003"],"award-info":[{"award-number":["2016003"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2020063"],"award-info":[{"award-number":["2020063"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["208197"],"award-info":[{"award-number":["208197"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["NS9013S"],"award-info":[{"award-number":["NS9013S"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["Toppforsk-250993"],"award-info":[{"award-number":["Toppforsk-250993"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["262529\/F20"],"award-info":[{"award-number":["262529\/F20"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.neo.2024.101023","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T12:34:28Z","timestamp":1719664468000},"page":"101023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancer"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-0249","authenticated-orcid":false,"given":"Mari","family":"Bogaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas M.","family":"Str\u00f8mme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1789-7523","authenticated-orcid":false,"given":"Susanne G.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1749-7423","authenticated-orcid":false,"given":"Bjarne","family":"Johannessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne C.","family":"Bakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1693-1032","authenticated-orcid":false,"given":"Ragnhild A.","family":"Lothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Axcrona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5609-4048","authenticated-orcid":false,"given":"Rolf I.","family":"Skotheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Axcrona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neo.2024.101023_bib0001","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1309\/AJCPZ7WBU9YXSJPE","article-title":"Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome","volume":"136","author":"Iczkowski","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.neo.2024.101023_bib0002","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2019.07.051","article-title":"Improved prostate cancer biopsy grading by incorporation of invasive cribriform and intraductal carcinoma in the 2014 Grade Groups","volume":"77","author":"van Leenders","year":"2020","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.neo.2024.101023_bib0003","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/JU.0000000000001290","article-title":"The prognostic impact of intraductal carcinoma of the prostate: a systematic review and meta-analysis","volume":"204","author":"Miura","year":"2020","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.neo.2024.101023_bib0004","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41379-018-0157-9","article-title":"Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis","volume":"32","author":"Hollemans","year":"2019","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.neo.2024.101023_bib0005","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41379-020-0625-x","article-title":"Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients","volume":"34","author":"Hollemans","year":"2021","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.neo.2024.101023_bib0006","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/modpathol.2014.116","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.neo.2024.101023_bib0007","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.humpath.2020.02.004","article-title":"Gleason pattern 4 with cribriform morphology on biopsy is associated with adverse clinicopathological findings in a prospective radical prostatectomy cohort","volume":"98","author":"Haffner","year":"2020","journal-title":"Hum. Pathol."},{"issue":"12","key":"10.1016\/j.neo.2024.101023_bib0008","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0b013e3182a02169","article-title":"Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma","volume":"37","author":"Dong","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"8","key":"10.1016\/j.neo.2024.101023_bib0009","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/pros.23326","article-title":"Intraductal carcinoma of the prostate on diagnostic needle biopsy predicts prostate cancer mortality: a population-based study","volume":"77","author":"S\u00e6ter","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.neo.2024.101023_bib0010","article-title":"Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis","author":"Russo","year":"2022","journal-title":"Prostate Cancer Prostatic. Dis."},{"key":"10.1016\/j.neo.2024.101023_bib0011","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.urology.2021.05.028","article-title":"Cribriform prostate cancer: clinical pathologic and molecular considerations","volume":"155","author":"Hesterberg","year":"2021","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.neo.2024.101023_bib0012","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12885-017-3976-z","article-title":"Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations","volume":"18","author":"B\u00f6ttcher","year":"2018","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.neo.2024.101023_bib0013","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/1541-7786.MCR-18-0440","article-title":"Genetic and epigenetic determinants of aggressiveness in cribriform carcinoma of the prostate","volume":"17","author":"Elfandy","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.neo.2024.101023_bib0014","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/bju.15530","article-title":"Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate","volume":"129","author":"Zhao","year":"2022","journal-title":"BJu Int."},{"issue":"5","key":"10.1016\/j.neo.2024.101023_bib0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.eururo.2017.04.034","article-title":"A prostate cancer \"Nimbosus\": genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies","volume":"72","author":"Chua","year":"2017","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.neo.2024.101023_bib0016","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neo.2021.05.012","article-title":"High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity","volume":"23","author":"Kidd","year":"2021","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.neo.2024.101023_bib0017","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/JU.0000000000000175","article-title":"Correlation of a commercial genomic risk classifier with histological patterns in prostate cancer","volume":"202","author":"Greenland","year":"2019","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.neo.2024.101023_bib0018","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/pros.23926","article-title":"Correlation between cribriform\/intraductal prostatic adenocarcinoma and percent Gleason pattern 4 to a 22-gene genomic classifier","volume":"80","author":"Taylor","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.neo.2024.101023_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.euf.2022.05.005","article-title":"Transcriptomic features of cribriform and intraductal carcinoma of the prostate","author":"Lone","year":"2022","journal-title":"Eur. Urol. Focus"},{"issue":"8","key":"10.1016\/j.neo.2024.101023_bib0020","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.neo.2024.101023_bib0021","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1001\/jamaoncol.2017.0751","article-title":"Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy","volume":"3","author":"Zhao","year":"2017","journal-title":"JAMa Oncol."},{"key":"10.1016\/j.neo.2024.101023_bib0022","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.humpath.2017.04.024","article-title":"PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform","volume":"65","author":"Ronen","year":"2017","journal-title":"Hum. Pathol."},{"issue":"11","key":"10.1016\/j.neo.2024.101023_bib0023","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/pros.23831","article-title":"PTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcinoma)","volume":"79","author":"Shah","year":"2019","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.neo.2024.101023_bib0024","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.eururo.2018.08.009","article-title":"Multifocal primary prostate cancer exhibits high degree of genomic heterogeneity","volume":"75","author":"L\u00f8vf","year":"2019","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.neo.2024.101023_bib0025","doi-asserted-by":"crossref","first-page":"13579","DOI":"10.1038\/s41598-019-49964-7","article-title":"Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer","volume":"9","author":"Carm","year":"2019","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.neo.2024.101023_bib0026","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1002\/1878-0261.13225","article-title":"In\u2009situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis","volume":"16","author":"Kidd","year":"2022","journal-title":"Mol. Oncol."},{"issue":"2","key":"10.1016\/j.neo.2024.101023_bib0027","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"issue":"7","key":"10.1016\/j.neo.2024.101023_bib0028","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/14737140.2018.1469406","article-title":"Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma","volume":"18","author":"Montironi","year":"2018","journal-title":"Expert. Rev. AntiCancer Ther."},{"key":"10.1016\/j.neo.2024.101023_bib0029","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41417-022-00444-7","article-title":"Expressed prognostic biomarkers for primary prostate cancer independent of multifocality and transcriptome heterogeneity","volume":"29","author":"Str\u00f8mme","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"12","key":"10.1016\/j.neo.2024.101023_bib0030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.neo.2024.101023_bib0031","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.neo.2024.101023_bib0032","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nmeth.3885","article-title":"Data-driven hypothesis weighting increases detection power in genome-scale multiple testing","volume":"13","author":"Ignatiadis","year":"2016","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.neo.2024.101023_bib0033","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","article-title":"RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues","volume":"14","author":"Wang","year":"2012","journal-title":"J. Mol. Diagn."},{"issue":"8","key":"10.1016\/j.neo.2024.101023_bib0034","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41419-021-04027-6","article-title":"CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer","volume":"12","author":"Lei","year":"2021","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.neo.2024.101023_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155901","article-title":"Validation of novel biomarkers for prostate cancer progression by the combination of bioinformatics, clinical and functional studies","volume":"11","author":"Alinezhad","year":"2016","journal-title":"PLoS One"},{"issue":"23_Supplement","key":"10.1016\/j.neo.2024.101023_bib0036","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.EPIMETAB20-PO-036","article-title":"Abstract PO-036: ACSM1 and ACSM3 regulate fatty acid oxidation in prostate cancer to promote growth and protect against oxidative stress","volume":"80","author":"Shrestha","year":"2020","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.neo.2024.101023_bib0037","first-page":"1824","article-title":"Oncogenic ACSM1 in prostate cancer is through metabolic and extracellular matrix-receptor interaction signaling pathways","volume":"12","author":"Guo","year":"2022","journal-title":"Am. J. Cancer Res."},{"issue":"8","key":"10.1016\/j.neo.2024.101023_bib0038","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1349-7006.2008.00846.x","article-title":"Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer","volume":"99","author":"Ohara","year":"2008","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.neo.2024.101023_bib0039","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1158\/1078-0432.CCR-04-0356","article-title":"Reg IV: a promising marker of hormone refractory metastatic prostate cancer","volume":"11","author":"Gu","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.neo.2024.101023_bib0040","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrn.2016.92","article-title":"Emerging roles of GluN3-containing NMDA receptors in the CNS","volume":"17","author":"P\u00e9rez-Ota\u00f1o","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neo.2024.101023_bib0041","unstructured":"Gene [Internet]. Bethesda, MD: National Library of Medicine (US), National Center for Biotechnology Information; 2004- [updated 2024 Jun 17; cited 2024 Jun 20]. GRIN3A glutamate ionotropic receptor NMDA type subunit 3A [Homo sapiens (human)] - Gene - NCBI. Available from: https:\/\/www.ncbi.nlm.nih.gov\/gene\/116443."},{"issue":"6","key":"10.1016\/j.neo.2024.101023_bib0042","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/his.15012","article-title":"High proliferative cribriform prostate cancer' defines a patient subgroup with an inferior prognosis","volume":"83","author":"Bogaard","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.neo.2024.101023_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2017.06.007","article-title":"Proliferation index of different Gleason pattern 4 histomorphologies and associated pattern 3 adenocarcinoma of the prostate","volume":"70","author":"Fu","year":"2017","journal-title":"Hum. Pathol."},{"issue":"8","key":"10.1016\/j.neo.2024.101023_bib0044","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 international society of urological pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.neo.2024.101023_bib0045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer","volume":"145","author":"Epstein","year":"2021","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.neo.2024.101023_bib0046","unstructured":"Mottet N., Cornford P., van den Bergh R.C.N., Briers E., Expert Patient Advocate (European Prostate Cancer Coalition\/Europa UOMO), De Santis M., et al. EAU\u2013EANM\u2013ESUR\u2013SIOG guidelines on prostate cancer. Edn. presented at the EAU Annual Congress Amsterdam 2022 Arnhem, The Netherlands: EAU Guidelines Office; 2022 [updated 2022 Mar; cited 2022 Sep 9]. Available from: https:\/\/uroweb.org\/guidelines\/prostate-cancer."},{"issue":"6","key":"10.1016\/j.neo.2024.101023_bib0047","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/bju.14812","article-title":"Multiparametric MRI prior to radical prostatectomy identifies intraductal and cribriform growth patterns in prostate cancer","volume":"124","author":"Tonttila","year":"2019","journal-title":"BJu Int."},{"issue":"1","key":"10.1016\/j.neo.2024.101023_bib0048","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.juro.2017.07.037","article-title":"A comprehensive analysis of cribriform morphology on magnetic resonance imaging\/ultrasound fusion biopsy correlated with radical prostatectomy specimens","volume":"199","author":"Truong","year":"2018","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.neo.2024.101023_bib0049","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/bju.15295","article-title":"Conspicuity of cribriform prostate cancer on multiparametric magnetic resonance imaging: the jury is still out","volume":"127","author":"Norris","year":"2021","journal-title":"BJu Int."},{"issue":"7","key":"10.1016\/j.neo.2024.101023_bib0050","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/modpathol.2016.63","article-title":"PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance","volume":"29","author":"Trock","year":"2016","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.neo.2024.101023_bib0051","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/PAP.0000000000000303","article-title":"Intraductal carcinoma of the prostate: a guide for the practicing pathologist","volume":"28","author":"Varma","year":"2021","journal-title":"Adv. Anat. Pathol."},{"issue":"7","key":"10.1016\/j.neo.2024.101023_bib0052","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/his.14665","article-title":"Current conundrums with cribriform prostate cancer","volume":"80","author":"Gordetsky","year":"2022","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.neo.2024.101023_bib0053","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.prp.2016.10.007","article-title":"Evaluation of ERG and PTEN protein expression in cribriform architecture prostate carcinomas","volume":"213","author":"Downes","year":"2017","journal-title":"Pathol. Res. Pract."},{"issue":"10","key":"10.1016\/j.neo.2024.101023_bib0054","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1593\/neo.06427","article-title":"TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions","volume":"8","author":"Cerveira","year":"2006","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.neo.2024.101023_bib0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.urolonc.2015.10.008","article-title":"ERG overexpression and multifocality predict prostate cancer in subsequent biopsy for patients with high-grade prostatic intraepithelial neoplasia","volume":"34","author":"Shah","year":"2016","journal-title":"Urol. Oncol."},{"issue":"4","key":"10.1016\/j.neo.2024.101023_bib0056","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/modpathol.2012.201","article-title":"Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia","volume":"26","author":"Lotan","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.neo.2024.101023_bib0057","unstructured":"Gene [Internet]. Bethesda, MD: National Library of Medicine (US), National Center for Biotechnology Information; 2004, [updated 2024 Jun 17; cited 2024 Jun 20]. ACSM1 acyl-CoA synthetase medium chain family member 1 [Homo sapiens (human)] - Gene - NCBI. Available from: https:\/\/www.ncbi.nlm.nih.gov\/gene\/116285."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:00:36Z","timestamp":1778616036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558624000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":57,"alternative-id":["S1476558624000654"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2024.101023","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2024.101023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101023"}}